(Q44601067)

4 December 2017

title

CD4-binding site alterations in CCR5-using HIV-1 envelopes influencing gp120-CD4 interactions and fusogenicity (English)

1 reference

4 December 2017

1

1 reference

4 December 2017

3

1 reference

4 December 2017

Anthony L. Cunningham

7

1 reference

4 December 2017

8

1 reference

4 December 2017

6

Steven L Wesselingh

1 reference

4 December 2017

Melissa J Churchill

2

1 reference

4 December 2017

Anne Ellett

4

1 reference

4 December 2017

William Farrugia

5

1 reference

4 December 2017

Paul R Gorry

9

1 reference

4 December 2017

language of work or name

English

0 references

publication date

8 January 2011

1 reference

4 December 2017

1 reference

4 December 2017

volume

410

1 reference

4 December 2017

issue

2

1 reference

4 December 2017

page(s)

418-428

1 reference

Multiple interactions across the surface of the gp120 core structure determine the global neutralization resistance phenotype of human immunodeficiency virus type 1

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

Core structure of gp41 from the HIV envelope glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

Determining the structure of an unliganded and fully glycosylated SIV gp120 envelope glycoprotein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

Structure of an unliganded simian immunodeficiency virus gp120 core

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

The first hypervariable region of the gp120 Env glycoprotein defines the neutralizing susceptibility of heterologous human immunodeficiency virus type 1 isolates to neutralizing antibodies elicited by the SF162gp140 immunogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

The crown and stem of the V3 loop play distinct roles in human immunodeficiency virus type 1 envelope glycoprotein interactions with the CCR5 coreceptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

Specific interaction of CCR5 amino-terminal domain peptides containing sulfotyrosines with HIV-1 envelope glycoprotein gp120

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

Beyond receptor expression: the influence of receptor conformation, density, and affinity in HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

The plasma membrane as a combat zone in the HIV battlefield

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

Determinants flanking the CD4 binding loop modulate macrophage tropism of human immunodeficiency virus type 1 R5 envelopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

Enhanced macrophage tropism of HIV in brain and lymphoid tissues is associated with sensitivity to the broadly neutralizing CD4 binding site antibody b12.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

The HIV Env variant N283 enhances macrophage tropism and is associated with brain infection and dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

Loss of the N-linked glycosylation site at position 386 in the HIV envelope V4 region enhances macrophage tropism and is associated with dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

Comparative protein structure modeling using MODELLER

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

Membrane-fusing capacity of the human immunodeficiency virus envelope proteins determines the efficiency of CD+ T-cell depletion in macaques infected by a simian-human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

Envelope glycoprotein determinants of increased fusogenicity in a pathogenic simian-human immunodeficiency virus (SHIV-KB9) passaged in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

The neuropathogenesis of AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

Increased CCR5 affinity and reduced CCR5/CD4 dependence of a neurovirulent primary human immunodeficiency virus type 1 isolate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

Uncoupling coreceptor usage of human immunodeficiency virus type 1 (HIV-1) from macrophage tropism reveals biological properties of CCR5-restricted HIV-1 isolates from patients with acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

Structure of a V3-containing HIV-1 gp120 core

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

The envelope glycoprotein ectodomains determine the efficiency of CD4+ T lymphocyte depletion in simian-human immunodeficiency virus-infected macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

Inference of macromolecular assemblies from crystalline state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

Importance of membrane fusion mediated by human immunodeficiency virus envelope glycoproteins for lysis of primary CD4-positive T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

PROCHECK: a program to check the stereochemical quality of protein structures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

Derivation and biological characterization of a molecular clone of SHIV(KU-2) that causes AIDS, neurological disease, and renal disease in rhesus macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

Differential CD4/CCR5 utilization, gp120 conformation, and neutralization sensitivity between envelopes from a microglia-adapted human immunodeficiency virus type 1 and its parental isolate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

HIV-1 tropism for the central nervous system: Brain-derived envelope glycoproteins with lower CD4 dependence and reduced sensitivity to a fusion inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

N-linked glycosylation of the V3 loop and the immunologically silent face of gp120 protects human immunodeficiency virus type 1 SF162 from neutralization by anti-gp120 and anti-gp41 antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

Energetics of the HIV gp120-CD4 binding reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

Intrapatient alterations in the human immunodeficiency virus type 1 gp120 V1V2 and V3 regions differentially modulate coreceptor usage, virus inhibition by CC/CXC chemokines, soluble CD4, and the b12 and 2G12 monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

Biological analysis of human immunodeficiency virus type 1 R5 envelopes amplified from brain and lymph node tissues of AIDS patients with neuropathology reveals two distinct tropism phenotypes and identifies envelopes in the brain that confer an enh

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

Variation in HIV-1 R5 macrophage-tropism correlates with sensitivity to reagents that block envelope: CD4 interactions but not with sensitivity to other entry inhibitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

Non-macrophage-tropic human immunodeficiency virus type 1 R5 envelopes predominate in blood, lymph nodes, and semen: implications for transmission and pathogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

The V1/V2 domain of gp120 is a global regulator of the sensitivity of primary human immunodeficiency virus type 1 isolates to neutralization by antibodies commonly induced upon infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

Neurological complications of HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

The V1-V3 region of a brain-derived HIV-1 envelope glycoprotein determines macrophage tropism, low CD4 dependence, increased fusogenicity and altered sensitivity to entry inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

Comparative protein modelling by satisfaction of spatial restraints

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

Envelope glycoprotein determinants of increased entry in a pathogenic simian-human immunodeficiency virus (SHIV-HXBc2P 3.2) passaged in monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

Mobility of the human immunodeficiency virus (HIV) receptor CD4 and coreceptor CCR5 in living cells: implications for HIV fusion and entry events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

Initial characterization of viral sequences from a SHIV-inoculated pig-tailed macaque that developed AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

A cell-free stock of simian-human immunodeficiency virus that causes AIDS in pig-tailed macaques has a limited number of amino acid substitutions in both SIVmac and HIV-1 regions of the genome and has offered cytotropism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

Asn 362 in gp120 contributes to enhanced fusogenicity by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

An altered and more efficient mechanism of CCR5 engagement contributes to macrophage tropism of CCR5-using HIV-1 envelopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

Macrophage entry mediated by HIV Envs from brain and lymphoid tissues is determined by the capacity to use low CD4 levels and overall efficiency of fusion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

Enhanced CD4+ cellular apoptosis by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with progressive HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

The antigenic structure of the HIV gp120 envelope glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

Effect of mutations in the second extracellular loop of CXCR4 on its utilization by human and feline immunodeficiency viruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

7 January 2021

Changes in human immunodeficiency virus type 1 envelope glycoproteins responsible for the pathogenicity of a multiply passaged simian-human immunodeficiency virus (SHIV-HXBc2)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

7 January 2021

Identification of CXCR4 domains that support coreceptor and chemokine receptor functions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

7 January 2021

A tyrosine-rich region in the N terminus of CCR5 is important for human immunodeficiency virus type 1 entry and mediates an association between gp120 and CCR5

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

7 January 2021

Diminished production of human immunodeficiency virus type 1 in astrocytes results from inefficient translation of gag, env, and nef mRNAs despite efficient expression of Tat and Rev

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

7 January 2021

Characterization of molecularly cloned simian-human immunodeficiency viruses causing rapid CD4+ lymphocyte depletion in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

7 January 2021

Persistent CCR5 utilization and enhanced macrophage tropism by primary blood human immunodeficiency virus type 1 isolates from advanced stages of disease and comparison to tissue-derived isolates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.12.010

7 January 2021

10.1016/J.VIROL.2010.12.010

Identifiers

DOI

1 reference

4 December 2017

1 reference